IRIS
BARISON, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.527
EU - Europa 5.895
AS - Asia 5.865
SA - Sud America 1.283
Continente sconosciuto - Info sul continente non disponibili 170
AF - Africa 144
OC - Oceania 8
Totale 23.892
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.968
SG - Singapore 2.109
IT - Italia 1.585
RU - Federazione Russa 1.472
CN - Cina 1.440
BR - Brasile 993
VN - Vietnam 870
GB - Regno Unito 857
DE - Germania 575
HK - Hong Kong 396
BD - Bangladesh 389
CA - Canada 364
UA - Ucraina 300
FR - Francia 226
SE - Svezia 207
FI - Finlandia 161
IN - India 143
MX - Messico 124
DK - Danimarca 118
AR - Argentina 110
PL - Polonia 92
TR - Turchia 80
ES - Italia 68
ID - Indonesia 65
NL - Olanda 65
IL - Israele 64
IQ - Iraq 59
ZA - Sudafrica 59
EC - Ecuador 57
IE - Irlanda 51
JP - Giappone 45
CO - Colombia 33
UZ - Uzbekistan 27
AT - Austria 25
VE - Venezuela 24
MA - Marocco 23
PK - Pakistan 23
AE - Emirati Arabi Uniti 22
PY - Paraguay 19
EG - Egitto 16
MY - Malesia 16
SA - Arabia Saudita 16
CL - Cile 14
LT - Lituania 14
JM - Giamaica 13
JO - Giordania 12
CH - Svizzera 11
EU - Europa 11
PE - Perù 11
TN - Tunisia 11
UY - Uruguay 11
CR - Costa Rica 10
PH - Filippine 10
HN - Honduras 9
KE - Kenya 9
AU - Australia 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
KZ - Kazakistan 7
BE - Belgio 6
CZ - Repubblica Ceca 6
GR - Grecia 6
IR - Iran 6
NI - Nicaragua 6
NP - Nepal 6
PS - Palestinian Territory 6
SV - El Salvador 6
BH - Bahrain 5
GY - Guiana 5
HR - Croazia 5
KG - Kirghizistan 5
LB - Libano 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BB - Barbados 4
BO - Bolivia 4
BY - Bielorussia 4
ET - Etiopia 4
MD - Moldavia 4
RO - Romania 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
CG - Congo 3
GT - Guatemala 3
HU - Ungheria 3
KR - Corea 3
KW - Kuwait 3
LV - Lettonia 3
OM - Oman 3
RS - Serbia 3
SM - San Marino 3
SN - Senegal 3
TW - Taiwan 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
GE - Georgia 2
GP - Guadalupe 2
Totale 23.696
Salva come PNG Salva come JPEG
Città #
Dallas 1.528
Singapore 1.102
Ashburn 756
San Jose 666
Beijing 606
Southend 444
Los Angeles 377
Hong Kong 361
Chicago 353
Houston 325
Chandler 314
Council Bluffs 289
Moscow 287
Ho Chi Minh City 266
Fairfield 252
Ann Arbor 242
New York 234
Woodbridge 226
San Mateo 200
Milan 189
Hanoi 164
Wilmington 160
Seattle 153
Rome 144
Buffalo 139
Santa Clara 136
Salt Lake City 133
The Dalles 132
Cambridge 131
Falls Church 129
São Paulo 117
Jacksonville 113
Dearborn 108
Ottawa 102
Boardman 95
Pisa 93
Tampa 93
Hefei 91
Lauterbourg 91
Helsinki 90
Portsmouth 79
Stevenage 79
Warsaw 78
Munich 72
Montreal 70
Brooklyn 68
Dong Ket 68
London 66
Columbus 64
Elk Grove Village 61
Mexico City 61
Orem 61
Lawrence 57
Beauharnois 56
Tel Aviv 55
Phoenix 50
Dublin 49
Toronto 48
Denver 47
Frankfurt am Main 45
Florence 43
Istanbul 43
Johannesburg 41
San Diego 40
Tokyo 40
Atlanta 39
Chennai 39
Stockholm 39
Sterling 35
Lancaster 34
Rio de Janeiro 34
Poplar 32
Amsterdam 31
Boston 29
Da Nang 28
Campinas 27
Naples 26
Tashkent 26
Turku 26
Guayaquil 25
Palermo 25
Bari 24
Haiphong 24
Genoa 23
Miami 23
Nuremberg 23
Turin 23
Figino 22
Lappeenranta 22
Redwood City 22
Central District 21
Montréal 21
Mumbai 21
Bologna 19
San Francisco 19
Belo Horizonte 18
Biên Hòa 18
Ankara 17
Baghdad 17
Dulles 17
Totale 13.761
Salva come PNG Salva come JPEG
Nome #
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.585
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 700
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 457
A simple echocardiographic score to rule out cardiac amyloidosis 394
A simple echocardiographic score to rule out cardiac amyloidosis 371
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 362
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 341
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 337
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 334
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 332
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 331
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 325
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 324
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 323
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 321
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 320
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 310
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 308
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 306
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 306
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 300
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 297
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 292
Sex-related differences in chronic heart failure 284
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 276
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy 273
Usefulness of Combined Functional Assessment by Cardiac Magnetic Resonance and Tissue Characterization Versus Task Force Criteria for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy 272
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 268
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 267
A Novel Homozygous Mutation of the Desmoplakin Gene With Biventricular Arrhythmogenic Cardiomyopathy 264
Leiomyosarcoma of the inferior vena cava in a patient with Budd-Chiari syndrome 263
Relationship between location and size of myocardial infarction and their reciprocal influences on post-infarction left ventricular remodelling 262
Update sui biomarcatori nello scompenso cardiaco. 262
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 261
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 257
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 247
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 247
Cardiac magnetic resonance in patients with muscular dystrophies 247
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study 244
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 243
Role of Imaging in Cardiomyopathies 241
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 241
Valvular heart disease in patients with cardiac amyloidosis 240
Fibrosis and mortality in patients with dilated cardiomyopathy [2] 239
Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study" 237
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 236
Cardiovascular disease and COVID-19: les liaisons dangereuses 232
Perspectives in noninvasive imaging for chronic coronary syndromes 229
Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance 226
CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: An international Registry 225
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 223
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology 221
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction 221
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis 219
Atypical progeroid syndrome and partial lipodystrophy due to LMNA gene p.R349W mutation 219
Molecular autopsy of sudden cardiac death in the genomics era 218
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 217
Scared to Death: Emotional Stress Causing Fatal Myocardial Infarction With Nonobstructed Coronary Arteries in Women 215
Increased extracellular volume fraction in nonischaemic dilated cardiomyopathy predicts worse outcomes independently of medical therapy 209
Colchicine added to standard therapy further reduces fibrosis in pigs with myocardial infarction 208
Long-Term Incremental Prognostic Value of Cardiovascular Magnetic Resonance After ST-Segment Elevation Myocardial Infarction. A Study of the Collaborative Registry on CMR in STEMI 207
Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy 205
Prevalence and prognostic impact of nonischemic late gadolinium enhancement in stress cardiac magnetic resonance 203
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology 202
Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction 200
Pressure-volume relationship by pharmacological stress cardiovascular magnetic resonance 199
Colchicine for the treatment of coronary artery disease 199
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 195
Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE-ICM International Registry 189
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: Results from a long-term follow-up multicentre study 187
Troponin in non-ischaemic dilated cardiomyopathy 179
Multimodality Imaging in a Patient With MINOCA and Anomalous Coronary Artery 177
Early or deferred cardiovascular magnetic resonance after ST-segment-elevation myocardial infarction for effective risk stratification 173
Prevalence and Correlates of Dilated and Non-Dilated Left Ventricular Cardiomyopathy in Transfusion-Dependent Thalassemia: Data from a National, Multicenter, Observational Registry 169
Pirfenidone is a cardioprotective drug: Mechanisms of action and preclinical evidence 169
Treatment of cardiac transthyretin amyloidosis: an update 164
Heart & kidney failure: Who's afraid of renin angiotensin system blockade? 163
Partial Lipodystrophy and LMNA p.R545H Variant 162
Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin 162
Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation 160
Cocaine and methamphetamine use and hospitalization for acute heart failure: Epidemiological evidence from a nationwide dataset 160
Magnetic Resonance for Differential Diagnosis of Left Ventricular Hypertrophy: Diagnostic and Prognostic Implications 158
Magnetic Resonance to Diagnose Cardiac Amyloidosis: Is it Already Time to Discard Contrast Agents? 136
The Barthel Index in elderly acute heart failure patients. Frailty matters 136
Echocardiography versus computed tomography and cardiac magnetic resonance for the detection of left heart thrombosis: a systematic review and meta-analysis 136
The unbearable underreporting of comorbidities in heart failure clinical trials 132
Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction 132
Response to ‘Is the left atrium the key in the amyloid imaging lock?’ 118
Extracellular Volume in Dilated Cardiomyopathy: A New Prognostic Marker on Top of Late Gadolinium Enhancement? 118
European task force reclassification of dilated and non-dilated cardiomyopathies identifies a high arrhythmic-risk overlap phenotype 103
Letter by Aimo et al Regarding Article, "development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies" 103
Prognostic role of updated Lake Louise criteria for the diagnosis of acute myocarditis (ITAMY-mapping study) 75
Changes in CMR-derived ventricular strain, fibrosis progression and outcomes in hypertrophic cardiomyopathy 74
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 66
Photon-Counting Computed Tomography for Tissue Characterization in Patients With a Left Ventricular Hypertrophic Phenotype 65
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 52
A Novel SCN5A Missense Variant Associated With Familial Non-Dilated Left Ventricular Cardiomyopathy 47
Electrocardiographic abnormalities in patients with cardiomyopathies 41
Applications of Artificial Intelligence in Amyloidosis 36
Late gadolinium enhancement dispersion for predicting malignant arrhythmic events in patient with non-ischaemic dilated cardiomyopathy 35
Totale 23.816
Salva come PNG Salva come JPEG
Categoria #
all - tutte 112.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.897
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022980 0 166 37 114 32 46 106 183 82 122 18 74
2022/2023689 62 49 31 94 88 99 11 60 105 16 52 22
2023/2024532 41 18 107 57 22 51 48 23 12 14 21 118
2024/20255.130 45 54 208 67 166 214 505 970 327 915 932 727
2025/202612.105 736 1.666 1.365 1.555 1.265 769 1.052 612 762 826 810 687
2026/2027604 267 337 0 0 0 0 0 0 0 0 0 0
Totale 23.892